AXSM Operating Cash Flow (Statement)
Axsome Therapeutics Inc · Operating Cash Flow (Statement)
AXSM Operating Cash Flow (Statement)
Latest reported-$71.26Mperiod ending
AXSM TTM Cash from Operations (-$4.60M → -$71.26M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AXSM operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -71,259,000 | |
| -70,730,000 | |
| -93,405,000 | |
| -100,954,000 | |
| -120,631,000 | |
| -118,318,000 | |
| -128,410,000 | |
| -132,570,000 | |
| -167,487,000 | |
| -192,726,000 | |
| -145,080,000 | |
| -142,281,242 | |
| -111,491,162 | |
| -89,678,818 | |
| -116,510,798 | |
| -117,788,075 | |
| -121,806,358 | |
| -113,663,255 | |
| -108,225,764 | |
| -99,938,762 | |
| -88,897,145 | |
| -82,398,874 | |
| -78,456,569 | |
| -75,470,203 | |
| -70,362,525 | |
| -60,149,033 | |
| -46,375,059 | |
| -38,601,857 | |
| -33,886,982 | |
| -32,872,472 | |
| -30,053,701 | |
| -26,550,982 | |
| -27,086,351 | |
| -26,515,667 | |
| -26,471,652 | |
| -27,397,097 | |
| -25,752,066 | |
| -23,970,119 | |
| -21,281,304 | |
| -16,315,483 | |
| -13,435,575 | |
| -10,227,749 | |
| -7,438,991 | |
| -7,135,030 | |
| -6,470,151 | |
| -5,059,286 | |
| -4,596,394 |